Skip to main content
. 2017 Apr 7;1(5):436–448. doi: 10.1210/js.2017-00006

Figure 1.

Figure 1.

Relationships of urinary F2-isoP and its metabolite with clinical parameters. (a) No correlation was observed between either the urinary F2-isoP or its metabolite with insulin sensitivity, as measured by glucose disposal rate via a hyperinsulinemic-euglycemic clamp. Both the urinary F2-isoprostane and its metabolite are negatively correlated with (b) LBM, (c) BMC, (d) and BMD. Cr, creatinine.